Jilu Zhang, PhD

Instructor of Oncology, Institute for Academic Medicine
Instructor, Research Institute
Houston Methodist

Publications

ST2/MyD88 Deficiency Protects Mice against Acute Graft-versus-Host Disease and Spares Regulatory T Cells

Griesenauer, B, Jiang, H, Yang, J, Zhang, J, Ramadan, AM, Egbosiuba, J, Campa, K & Paczesny, S 2019, Journal of immunology (Baltimore, Md. : 1950), vol. 202, no. 10, pp. 3053-3064. https://doi.org/10.4049/jimmunol.1800447

Rorc restrains the potency of ST2+ regulatory T cells in ameliorating intestinal graft-versus-host disease

Yang, J, Ramadan, A, Reichenbach, DK, Loschi, M, Zhang, J, Griesenauer, B, Liu, H, Hippen, KL, Blazar, BR & Paczesny, S 2019, JCI insight, vol. 4, no. 5. https://doi.org/10.1172/jci.insight.122014

The mechanistic study behind suppression of GVHD while retaining GVL activities by myeloid-derived suppressor cells

Zhang, J, Chen, H-M, Ma, G, Zhou, Z, Raulet, D, Rivera, AL, Chen, S-H & Pan, P-Y 2019, Leukemia. https://doi.org/10.1038/s41375-019-0394-z

Blocking immunoinhibitory receptor LILRB2 reprograms tumor-associated myeloid cells and promotes antitumor immunity

Chen, H-M, van der Touw, W, Wang, YS, Kang, K, Mai, S, Zhang, J, Alsina-Beauchamp, D, Duty, JA, Mungamuri, SK, Zhang, B, Moran, T, Flavell, R, Aaronson, S, Hu, H-M, Arase, H, Ramanathan, S, Flores, R, Pan, P-Y & Chen, S-H 2018, The Journal of clinical investigation, vol. 128, no. 12, pp. 5647-5662. https://doi.org/10.1172/JCI97570

From proteomics to discovery of first-in-class ST2 inhibitors active in vivo

Ramadan, AM, Daguindau, E, Rech, JC, Chinnaswamy, K, Zhang, J, Hura, GL, Griesenauer, B, Bolten, Z, Robida, A, Larsen, M, Stuckey, JA, Yang, CY & Paczesny, S 2018, JCI Insight, vol. 3, no. 14. https://doi.org/10.1172/jci.insight.99208

Leukocyte immunoglobulin-like receptors in human diseases: An overview of their distribution, function, and potential application for immunotherapies

Zhang, J, Mai, S, Chen, H-M, Kang, K, Li, XC, Chen, SH & Pan, PY 2017, Journal of Leukocyte Biology, vol. 102, no. 2, pp. 351-360. https://doi.org/10.1189/jlb.5MR1216-534R

Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease

Li, W, Liu, L, Gomez, A, Zhang, J, Ramadan, A, Zhang, Q, Choi, SW, Zhang, P, Greenson, JK, Liu, C, Jiang, D, Virts, E, Kelich, SL, Chu, HW, Flynn, R, Blazar, BR, Hanenberg, H, Hanash, S & Paczesny, S 2016, JCI Insight, vol. 1, no. 6. https://doi.org/10.1172/jci.insight.86660

ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease

Zhang, J, Ramadan, AM, Griesenauer, B, Li, W, Turner, MJ, Liu, C, Kapur, R, Hanenberg, H, Blazar, BR, Tawara, I & Paczesny, S 2015, Science Translational Medicine, vol. 7, no. 308, 308ra160. https://doi.org/10.1126/scitranslmed.aab0166

Therapeutic effects and possible mechanisms of sirolimus on nephritic mice with chronic rejection

Zheng, MK, Hou, CM, Wang, RX, Wei, YL, Zhang, J, Li, XY, Chen, GJ, Han, GC, Shen, BF, Li, Y, Ma, YF & Xiao, H 2014, Journal of International Pharmaceutical Research, vol. 41, no. 3, pp. 335-341. https://doi.org/10.13220/j.cnki.jipr.2014.03.014

[Influence of excessive complement activation on pathological process of acute graft versus host disease in mice].

Zhang, J, Hou, CM, Wei, YL, Li, XY, Sun, DJ, Feng, JN, Li, Y, Shen, BF & Xiao, H 2010, Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology, vol. 18, no. 6, pp. 1585-1589.

CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3 + regulatory T cells in the target tissue: Kidney

Zhang, J, Sun, DJ, Hou, CM, Wei, YL, Li, XY, Yu, ZY, Feng, JN, Shen, BF, Li, Y & Xiao, H 2010, Transplant Immunology, vol. 24, no. 1, pp. 17-25. https://doi.org/10.1016/j.trim.2010.09.002

Reply to "reply to 'The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rates in hematologic malignancy patients: Outcome of a pilot clinical study' by Ning H et al." by Behre et al

Ning, H, Yang, F, Jiang, M, Hu, L, Feng, K, Zhang, J, Yu, Z, Li, B, Xu, C, Li, Y, Wang, J, Hu, J, Lou, X & Chen, H 2009, Leukemia, vol. 23, no. 1, pp. 179-180. https://doi.org/10.1038/leu.2008.151

The correlation between cotransplantation of mesenchymal stem cells and higher recurrence rate in hematologic malignancy patients: Outcome of a pilot clinical study

Ning, H, Yang, F, Jiang, M, Hu, L, Feng, K, Zhang, J, Yu, Z, Li, B, Xu, C, Li, Y, Wang, J, Hu, J, Lou, X & Chen, H 2008, Leukemia, vol. 22, no. 3, pp. 593-599. https://doi.org/10.1038/sj.leu.2405090

VIEW FULL PUBLICATIONS